Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: DOXIL for Consolidation Therapy in Ovarian Cancer. [Phase 2]
This clinical trial update reports Phase 2 results for DOXIL as consolidation therapy in ovarian cancer, with the study status completed.
-
FDA approval · 2011-10-07FDA Approved: HYCAMTIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for HYCAMTIN (topotecan) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors [NA]
This update notes the completion of a University of Utah clinical trial evaluating exercise to improve mobility and reduce fatigue in older …
-
CLINICAL_TRIALS trial_result · 2011-09-26Clinical Trial Update: Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin [Phase 2]
A Phase 2 study evaluating the combination of imatinib mesylate and paclitaxel in recurrent ovarian cancer and Mullerian-origin cancers was …
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer [Phase 2]
AZD0530 (saracatinib) was evaluated in a Phase II trial for patients with advanced ovarian cancer. The study has completed and results were …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery
Clinical trial update describing an intra-operative goal-directed haemodynamic management algorithm for non-cardiac surgery, with studied co…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Clinical Benefit of Topoisomerase Downregulation [Phase 1]
Phase 1 trial evaluating topoisomerase downregulation in ovarian cancer has completed and reports clinical benefit.
-
FDA approval · 2011-08-26FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the …
-
CLINICAL_TRIALS research · 2011-08-08Clinical Trial Update: Pharmacogenomics of Paclitaxel in Ovarian Cancer
Completed clinical trial from the University of Southern Denmark examining pharmacogenomics of paclitaxel in ovarian and fallopian tube canc…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 study of TLK286 for platinum-resistant advanced epithelial ovarian cancer has completed. The update does not include results in the …
-
FDA approval · 2011-07-25FDA Approved: GEMCITABINE HYDROCHLORIDE — Original Application (Teyro Labs Private Limited)
The FDA approved an original ANDA for gemcitabine hydrochloride from Teyro Labs Private Limited, enabling its generic use.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer [Phase 3]
This is a completed Phase 3 trial comparing TLK286 (Telcyta) to Doxil/Caelyx or Hycamtin in platinum-refractory or resistant ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer [Phase 1, Phase 2]
This is an update on a Phase 1/2 trial of TLK286 in combination with carboplatin for recurrent ovarian cancer. The study has completed enrol…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase 1/Phase 2 study evaluating TLK286 in combination with Doxil for platinum-refractory…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating topotecan in combination with gemcitabine for platinum-resista…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
A Mayo Clinic-sponsored clinical trial studying circulating cancer cells in patients with metastatic breast, ovarian, colorectal, or pancrea…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer [Phase 3]
Phase 3 trial update evaluating hyperbaric oxygen therapy to treat long-term gastrointestinal adverse effects caused by pelvic cancer radiat…
-
FDA approval · 2011-07-14FDA Approved: MELPHALAN HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Melphalan Hydrochloride from Mylan Institutional LLC, authorizing the generic drug's continued m…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families [Phase 3]
Phase 3 trial comparing a web-based stem cell transplant support system to standard care in young patients undergoing stem cell transplant a…
-
CLINICAL_TRIALS withdrawal · 2011-07-08Clinical Trial Update: Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer [Phase 1]
Phase 1 trial of capecitabine with radiation therapy for locally advanced cervical cancer or other pelvic cancers was withdrawn; sponsor Cas…
-
FDA approval · 2011-06-29FDA Approved: DOCETAXEL — Original Application (Baxter Healthcare Corporation)
FDA approved the original application for docetaxel by Baxter Healthcare Corporation, marking its initial U.S. approval as a cancer therapy.…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Bone Health in Gynecologic Cancers-does FOSAVANCE Help? [Phase 2]
Phase 2 trial evaluating Fosavance for bone health in ovarian cancer has completed. The study explored whether Fosavance provides bone healt…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer [Phase 1, Phase 2]
The document reports a completed Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody in combination with peripheral stem …
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating pemetrexed in combination with carboplatin in patients with recurrent ovarian cancer or primary peritoneal cancer…
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: Health and Coping Prior to Ovarian Cancer Surgery [NA]
A completed clinical trial update from the University of Aarhus examining health and coping in patients undergoing ovarian cancer surgery.